menu
    • menu

    Company profile for Phesi

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. Our integrated offerings cover the entire clinical development process — from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management. Transform clinical development design, planning and delivery through the use of dynamically u...
    Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. Our integrated offerings cover the entire clinical development process — from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management. Transform clinical development design, planning and delivery through the use of dynamically updated, real-world data analytics and insights.Improve program efficiency and reduce costs across all phases of development and all therapeutic areas

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PhesiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Applewood Common, East Lyme, Connecticut 06333
    Telephone
    Telephone
    +1 (800) 679 0068
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.phesi.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Global oncology trial investigator sites increase by half in five years, Phesi
    Global oncology trial investigator sites increase by half in five years, Phesi

    23 May 2024

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2024-05-23/global-oncology-trial-investigator-sites-increase-by-half-in-five-years-finds-new-phesi-analysis

    PHARMIWEB
    23 May 2024
    Share Share
    New metric predicts burden of participating in trials
    New metric predicts burden of participating in trials

    09 May 2024

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/new-metric-predicts-burden-participating-trials

    Phil Taylor PHARMAPHORUM
    09 May 2024
    Share Share
    Phesi in pact with Krystelis to improve trial diversity efforts
    Phesi in pact with Krystelis to improve trial diversity efforts

    13 Sep 2023

    // Joseph Keenan FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/phesi-pact-krystelis-improve-trial-diversity-efforts

    Joseph Keenan FIERCE BIOTECH
    13 Sep 2023
    Share Share
    Phesi publishes first edition of Digital Patient Profile Catalog enable adoption
    Phesi publishes first edition of Digital Patient Profile Catalog enable adoption

    03 May 2023

    // BUSINESSWIRE

    https://www.pharmiweb.com/press-release/2023-05-03/phesi-publishes-first-edition-of-digital-patient-profile-catalog-to-enable-adoption-of-digital-twins-and-improve-patient-centricity-in-drug-developmen

    BUSINESSWIRE
    03 May 2023
    Share Share
    Phase 2 attrition jumps amid scale-back in trial activity
    Phase 2 attrition jumps amid scale-back in trial activity

    18 Jan 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/phase-2-attrition-jumps-amid-widespread-scale-back-overall-clinical-trial-activity-study

    Nick Paul Taylor FIERCE BIOTECH
    18 Jan 2023
    Share Share
    Phesi touts new AI platform could save $7M per phase 3 trial
    Phesi touts new AI platform could save $7M per phase 3 trial

    20 Oct 2022

    // Joseph Keenan FIERCEBIOTECH

    https://www.fiercebiotech.com/cro/phesi-touts-new-ai-platform-could-save-7m-p3-trial

    Joseph Keenan FIERCEBIOTECH
    20 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search